Immunosuppression Post-Liver Transplant End of the Calcineurin Era?

被引：0
|
作者：
Yataco, Maria L. [1 ]
Keaveny, Andrew P. [1 ]
机构：
[1] Mayo Clin, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
来源：
CLINICS IN LIVER DISEASE | 2025年 / 29卷 / 02期
关键词：
Immunosuppression; Liver transplantation; Calcineurin inhibitor; Everolimus; Tolerance; MYCOPHENOLATE-MOFETIL; RENAL-FUNCTION; OPERATIONAL TOLERANCE; DOSE TACROLIMUS; CYCLOSPORINE-A; RECIPIENTS; REJECTION; EVEROLIMUS; SIROLIMUS; FK-506;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：287 / 302
页数：16
相关论文
共 50 条
  • [21] POST-LIVER TRANSPLANT HBV INFECTION (REVIEW)
    Nikogosova, A. D.
    Umrik, D., V
    Tsirulnikova, O. M.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2022, 24 (02): : 31 - 38
  • [22] Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Boillot, Olivier
    Giostra, Emiliano
    Dumortier, Jerome
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 660 - 669
  • [23] Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression
    Lim, E. J.
    Crowley, P.
    Mitchell, C. A.
    Angus, P. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (01) : 169 - 172
  • [24] Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
    Ivulich, Steven
    Paul, Eldho
    Kirkpatrick, Carl
    Dooley, Michael
    Snell, Greg
    TRANSPLANT INTERNATIONAL, 2023, 36
  • [25] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [26] Immune monitoring of immunosuppression withdrawal of liver transplant recipients
    Garcia de la Garza, Rocio
    Sarobe, Pablo
    Merino, Juana
    Lasarte, Juan J.
    D'Avola, Delia
    Belsue, Virginia
    Delgado, Jose A.
    Silva, Leyre
    Inarrairaegui, Mercedes
    Sangro, Bruno
    Sola, Iosu
    Pardo, Fernando
    Quiroga, Jorge
    Herrero, J. Ignacio
    TRANSPLANT IMMUNOLOGY, 2015, 33 (02) : 110 - 116
  • [27] THE ROLE OF ENDOVASCULAR AND ENDOBILIARY METHODS IN THE TREATMENT OF POST-LIVER TRANSPLANT COMPLICATIONS
    Gautier, S., V
    Voskanov, M. A.
    Monakhov, A. R.
    Semash, K. O.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2020, 22 (04): : 140 - 148
  • [28] Audit of eosinophilic oesophagitis in children post-liver transplant
    Noble, C.
    Francis, L.
    Withers, G. W.
    Ee, L. C.
    Lewindon, P. J.
    PEDIATRIC TRANSPLANTATION, 2009, 13 (07) : 827 - 830
  • [29] Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients
    Mulgaonkar, Shamkant
    Kaufman, Dixon B.
    CLINICAL TRANSPLANTATION, 2014, 28 (11) : 1209 - 1224
  • [30] Immunosuppression, liver injury and post-transplant HCV recurrence
    Ciesek, S.
    Wedemeyer, H.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (01) : 1 - 8
12345